Drug
Cotsiranib clinical trials
Also written STP705.
- studies test it
- 10
- open now
- 1
- in phase 3
- 0
- first study started
- 2017
Keep track of what changes. Save the cotsiranib studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- STP705
- 10
Studies by the year they started
10 studies that test it; most in 2021 (4)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Sirnaomics (10)
Studies
Open first, then newest update. How each study uses cotsiranib is read from its arms, and is right about nine times in ten.
Testing it · 10
- STP705 Injection for Submental Fat ReductionRecruitingPhase 2SirnaomicsNCT07677683Written as STP705
- Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Adults With Facial isSCCTerminatedPhase 1/2SirnaomicsNCT05421013Written as STP705
- Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell CarcinomaCompletedPhase 2SirnaomicsNCT04669808Written as STP705
- Safety, Tolerability, Pharmacokinetics, Immunogenicity and Efficacy of STP705 in Adult Patients With Hypertrophic ScarsWithdrawnPhase 1/2SirnaomicsNCT05196373Written as STP705
- A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid RecurrenceCompletedPhase 2SirnaomicsNCT04844840Written as STP705
- Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard TherapyCompletedPhase 1SirnaomicsNCT04676633Written as STP705
- A Study to Evaluate Safety, Tolerability of Subcutaneous Injection in Adult Subjects Undergoing AbdominoplastyCompletedPhase 1SirnaomicsNCT05422378Written as STP705
- A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCCCompletedPhase 2SirnaomicsNCT04844983Written as STP705
- Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCCCompletedPhase 1/2SirnaomicsNCT04293679Written as STP705
- A Randomized Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Subjects With Hypertrophic ScarCompletedPhase 1/2SirnaomicsNCT02956317Written as STP705
Codes
What other systems call cotsiranib · ClinicalTrials.gg INT018719
- UNII (FDA) ZT3VR2T6GYCOTSIRANIBOne source FDA
- NCI Thesaurus C175941CotsiranibOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | ZT3VR2T6GY | COTSIRANIB | One source FDA |
| NCI Thesaurus | C175941 | Cotsiranib | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.